SCHEMBL18647419

SCHEMBL18647419

Clc1nc2c3ccccc3c3c4ccccc4sc3c2c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 3/20 0.40
▸ TNKS O95271 3/20 0.40
▸ TNKS2 Q9H2K2 3/20 0.40
▸ LIMK1 P53667 1/20 0.37
▸ CDK5 Q00535 1/20 0.37
▸ CDK5R1 Q15078 1/20 0.37
▸ MAPT P10636 4/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ GPR3 P46089 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ LOXL2 Q9Y4K0 1/20 0.34
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ KRAS P01116 1/20 0.33
▸ MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18646710 0.89 EGLN1 (0.39) EGLN1TNKSTNKS2LIMK1CDK5
SCHEMBL18646834 0.89 EGLN1 (0.43) EGLN1TNKSTNKS2LIMK1CDK5
SCHEMBL18646817 0.87 EGLN1 (0.42) EGLN1TNKSTNKS2LIMK1CDK5
SCHEMBL18416391 0.84 EGLN1 (0.40) EGLN1TNKSTNKS2LIMK1CDK5
SCHEMBL18647316 0.81 GPR3 (0.41) EGLN1LIMK1CDK5CDK5R1MAPT
SCHEMBL15766144 0.80 LIMK1 (0.45) EGLN1TNKSTNKS2LIMK1CDK5
SCHEMBL18647350 0.79 GPR3 (0.42) EGLN1TNKSTNKS2LIMK1CDK5
SCHEMBL17689841 0.74 GPR3 (0.57) TNKSTNKS2LIMK1CDK5CDK5R1
SCHEMBL18646213 0.74 TNKS (0.35) EGLN1TNKSTNKS2LIMK1CDK5
SCHEMBL18416390 0.73 EGLN1 (0.44) EGLN1TNKSTNKS2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968208-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2021-04-06 — — US disclosed
US-20200223835-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2020-07-16 — — US disclosed
WO-2017043797-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2017-03-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968208-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof PIEZO1, OCIAD1, EML4 EGLN1 2766/4885TNKS 3823/4885TNKS2 4040/4885
US-20200223835-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, EML4 EGLN1 2766/4885TNKS 3823/4885TNKS2 4040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback